Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Salary: £33,966 to £44,263 per annum Newcastle University is a great place to work, with excellent benefits . We have a generous holiday package; plus the opportunity to buy more, great pension
-
/Senior Research Associate position is available in the Newcastle Cancer Centre Pharmacology Group of Professor Gareth Veal, at the Newcastle University Centre for Cancer, to develop novel immunoassays
-
funding applications Participating in activities of the Population Health Research Institute and the Newcastle University Centre for Cancer If required, contributing to the supervision of undergraduate and
-
funding applications Participating in activities of the Population Health Research Institute and the Newcastle University Centre for Cancer If required, contributing to the supervision of undergraduate and
-
Salary: Lecturer F: £39,347 to £44,263 per annum Lecturer G: £45,585 to £54,395 per annum Senior Lecturer H: £56,021 to £64,914 per annum Newcastle University is a great place to work, with
-
in gene regulation. The successful applicant will work as part of an interdisciplinary team, and in close collaboration with experimental biologists at the Newcastle University Centre for Cancer
-
Cano https://www.ncl.ac.uk/nes/people/profile/celinecano.html Newcastle University Centre for Cancer Eligibility Criteria You must have, or expect to achieve, at least a 2:1 Honours degree
-
Foundation Supervisors Dr. Shoba Amarnath , Biosciences Institute, Newcastle University Dr. Arian Laurence , University College London Hospitals (External) Dr. Katie Smith , Biosciences Institute, Newcastle
-
the activity of HIF-1 and HIF-2 in disease relevant models. Number Of Awards 1 Start Date 30th September 2024 Award Duration 3 years Application Closing Date 14th June 2024 Sponsor Newcastle University Academic
-
Genome Biology at the University of Leicester. You will work on a project funded by the Prostate Cancer Research and jointly led by Newcastle University, UK. This project aims to examine whether targeting